News - Gilde Healthcare


Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis

Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led by Advent Life Sciences. In addition to Gilde Healthcare the round also included returning investors New Enterprise Associates (NEA), Future Fund, Vertex Healthcare, GBS Venture...
August 16, 2022
These were all messages